Filter per year
September 29, 2023
Media Update: Sanofi completes acquisition of Qunol®
September 26, 2023
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review
September 25, 2023
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A
September 22, 2023
Press Release: Availability of the Q3 2023 Memorandum for modelling purposes
September 19, 2023
Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change
September 14, 2023
Media Update: New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMD
September 5, 2023
Media Update: New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions 
August 31, 2023
Press Release: Sanofi announces changes to its Executive Committee
August 28, 2023
Press Release: Sanofi, Meningitis Research Foundation, and the Confederation of Meningitis Organisations ignite a global awareness initiative against meningitis with launch of The Meningitis Flag
August 3, 2023
Press Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
July 28, 2023
Press release: Online availability of Sanofi’s half-year financial report for 2023
July 28, 2023
Press Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment
July 28, 2023
Press Release: Solid Q2 performance and strong pipeline momentum, Full-year 2023 business EPS guidance raised
July 17, 2023
Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
June 29, 2023
Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease
June 27, 2023
Press Release: Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibody
June 25, 2023
Press Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosing
June 22, 2023
Press Release: Availability of the Q2 2023 Memorandum for modelling purposes
June 20, 2023
Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim
June 14, 2023
Press Release: Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care

Press Statements